Janz Syndrome: Clinical Case Report in Ecuador
DOI:
https://doi.org/10.31243/mdc.uta.v5i4.1422.2021Keywords:
Syndrome, Epilepsy, Seizures, Myoclonus, Diagnosis, AdolescentAbstract
Introduction: Janz Syndrome or Juvenile Myoclonic Epilepsy generally begins in puberty or adolescence, it has an idiopathic-hereditary etiology that presents myoclonic jerks, generalized tonic-clonic seizures that are produced by sleep deprivation, alcohol intake, among others. . Few cases have been reported internationally, giving an estimated 1 case per 1000-2000 people, currently there are no cases reported in Ecuador, this because in many cases this disease is underdiagnosed. The treatment of choice is Valproic Acid, although it has been shown that treatment with Levetiracetam has given good results.
Objective: Describe a clinical case of a young patient who presents Juvenile Myoclonic Epilepsy, analyzing the clinical-electroencephalographic characteristics and emphasize the need for an adequate diagnosis and treatment.
Material and methods: Retrospective descriptive study, clinical case presentation.
Results: A clinical case of a 24-year-old female patient with a pathological history of essential myoclonus of the arms from the age of 16 with sporadic appearance is presented, who visits a private doctor who prescribes Valproic Acid 500 mg orally 2 times a day with apparent improvement, 4 years later, an episode of generalized tonic clonic seizure appears, this same episode is repeated 9 times during 2 years, currently being treated with Levetiracetam 2000 mg orally every day.
Conclusions: It can be concluded that Janz Syndrome is a pathology that is difficult to diagnose and that with proper treatment there is a favorable response to the different anticonvulsants, achieving an adequate quality of life
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
